---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-25-000010"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:30:15.453847+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health signs 5-year lab services pact with Mayo Clinic

## Summary
- Aspira will provide Ova1Plus and OvaWatch tests to Mayo on a non-exclusive, as-requested basis for clinical purposes.
- Initial term of 5 years, automatic annual renewals; either party may terminate with 90 days' notice.
- Mayo to list tests in its catalog, handle ordering, results delivery, and billing; Aspira invoices Mayo.
- Fees fixed during initial term absent mutual adjustment; agreement not yet filed due to redactions.

## SEC filing metadata
- accession: 0000926617-25-000010
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661725000010/0000926617-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661725000010/awhl-20251216x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-25-000010
- JSON: https://secwatch.observer/filing/0000926617-25-000010.json
- Plain text: https://secwatch.observer/filing/0000926617-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.